This 4th Biologics and Biosimilars Congress 2018 is a conference will provide in-depth studies of antibody therapeutics, biotherapeutic development and biologics for immunotherapy, including oncology and treatment of autoimmune disease and an expanded session on Antibody-Drug Conjugates, as well as a session examining recent clinical and regulatory developments in biosimilars.
Topics
- Advances in treatments across the Blood Brain Barrier
- Design of monoclonal and recombinant antibody therapeutics
- Treatments for autoimmune disease
- Immunotherapy and immuno-oncology
- ADC Payload and linker design
- Design and optimisation of Antibody-Drug Conjugates
- Advances in overcoming immunogenicity
- Protein biotherapeutics and protein expression
- Biosimilar regulatory and market barriers
- Optimisation biosimilar design and production
